|Articles|March 1, 2004
- BioPharm International-03-01-2004
- Volume 17
- Issue 3
Tefen Operations Excellence
On March 25, 2004 Centocor will host the first meeting of the European chapter in Leiden, Holland. Wyeth BioPharma and Genzyme have co-sponsored the establishment of this European group; other leading companies - such as Lonza Biologics, Celltech, and Baxter Bioscience - have joined the forum.
Advertisement
On March 25, 2004 Centocor will host the first meeting of the European chapter in Leiden, Holland. Wyeth BioPharma and Genzyme have co-sponsored the establishment of this European group; other leading companies - such as Lonza Biologics, Celltech, and Baxter Bioscience - have joined the forum.
For more information about the consortium and details on future meetings please e-mail us at
Articles in this issue
over 21 years ago
Qualifying Release Laboratories in Europe and the United Statesover 21 years ago
Keeping Biopharmaceutical Cleanrooms Compliantover 21 years ago
Site Expansion - Regional Roundup: Pennsylvaniaover 21 years ago
Site Expansion - Regional Roundup: Delawareover 21 years ago
Final Word: Beware of Patent Infringement During Discovery Researchover 21 years ago
StreetTalk: It Takes Two (Or Does It?)Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
